한글목차

세계의 신경보철 시장 규모는 2024년에 134억 6,000만 달러, 2030년에는 274억 8,000만 달러에 달할 것으로 예측되며, 예측 기간 중 연평균 성장률(CAGR)은 12.61%로 추이할 것으로 예측됩니다.

이 시장은 기술 혁신과 진화하는 헬스케어 요구의 에 힘입어 크게 확대될 것으로 보입니다.

주요 성장요인은 파킨슨병, 간질, 척수 손상, 뇌졸중과 같은 신경질환의 유병률이 증가하고 있으며, 특히 고령화가 진행되고 있다는 점입니다. 이러한 질환의 발생률이 증가함에 따라 환자 중심의 첨단 신경보철 솔루션에 대한 수요도 증가하고 있습니다.

뇌-컴퓨터 인터페이스(BCI)와 신경 임플란트와 같은 기술의 혁신은 치료와 재활에 새로운 길을 열어 신경질환을 관리하는 방식을 변화시키고 있습니다. 공공 및 민간의 자금 지원과 규제 프레임워크가 강화되면서 연구개발 및 상용화를 위한 역동적인 생태계가 형성되고 있습니다.

시장 성장 촉진요인

신경질환의 유병률 상승

주요 시장이 해결해야 할 과제

생체 적합성과 안전성에 대한 우려

주요 시장 동향

브레인-컴퓨터 인터페이스(BCI)의 진보

목차

제1장 개요

제2장 조사 방법

제3장 개요

제4장 고객의 소리

제5장 세계의 신경보철 시장 전망

• 시장 규모·예측
  • 금액별
• 시장 점유율·예측
  • 유형별(출력 신경보철, 입력 신경보철)
  • 기술별(척수 자극, 뇌심부 자극, 미주신경 자극, 기타 기술)
  • 용도별(파킨슨병, 알츠하이머병, 간질, 청각 처리 장애, 안질환, 기타 용도)
  • 기업별(2024)
  • 지역별
• 시장 맵

제6장 북미의 신경보철 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제7장 유럽의 신경보철 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 신경보철 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 한국
  • 일본
  • 호주

제9장 남미의 신경보철 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 신경보철 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트

제11장 시장 역학

• 촉진요인
• 과제

제12장 시장 동향과 발전

• 합병과 인수
• 제품 출시
• 최근 동향

제13장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제14장 경쟁 구도

• Medtronic PLC
• LivaNova PLC
• Demant A/S
• MED-EL Corporation
• Cochlear Limited
• Abbott Laboratories
• Boston Scientific Corp
• Second Sight Medical Products, Inc.
• Retina Implant AG
• NeuroPace Inc

제15장 전략적 제안

제16장 조사회사 소개·면책사항

영문목차

Global Neuroprosthetics Market was valued at USD 13.46 billion in 2024 and is projected to reach USD 27.48 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.61% during the forecast period. This market is witnessing significant expansion, fueled by the convergence of technological innovation and evolving healthcare needs.

A key growth driver is the rising prevalence of neurological disorders-such as Parkinson's disease, epilepsy, spinal cord injuries, and stroke-particularly among aging populations. As the incidence of these conditions increases, so does the demand for advanced, patient-centric neuroprosthetic solutions.

Breakthroughs in technologies like brain-computer interfaces (BCIs) and neural implants are opening new avenues for treatment and rehabilitation, transforming how neurological conditions are managed. Enhanced funding from public and private sectors, along with supportive regulatory frameworks, is fostering a dynamic ecosystem for research, development, and commercialization.

Key Market Drivers

Rising Prevalence of Neurological Disorders

One of the primary drivers of growth in the neuroprosthetics market is the increasing global burden of neurological disorders. These include a wide array of conditions such as Parkinson's disease, epilepsy, Alzheimer's disease, spinal cord injuries, and stroke.

The global aging population is a significant contributor to this trend. According to the United Nations' World Population Ageing 2023 report, the number of individuals aged 65 and older is expected to rise sharply in the coming decades. For example, in the United States, the Population Reference Bureau projects that the population aged 65 and above will grow from 58 million in 2022 to 82 million by 2050-a 47% increase. Given the higher prevalence of neurodegenerative conditions among older adults, this demographic shift is expanding the potential user base for neuroprosthetic devices.

Key Market Challenges

Biocompatibility and Safety Concerns

Biocompatibility and safety remain critical challenges in the neuroprosthetics sector. These devices, which interact directly with the nervous system, must be designed to integrate seamlessly with biological tissues to prevent adverse immune responses and ensure long-term efficacy.

One major issue is the potential for immune rejection, where the body identifies the implanted device as a foreign object, leading to inflammation, discomfort, or even device failure. Ensuring that materials used are non-reactive and biocompatible is essential to mitigating these risks.

Another concern involves infection, especially with devices that include external components penetrating the skin barrier. Such infections can compromise both the function of the device and patient health, underscoring the importance of hygienic design and high-quality materials.

Long-term reliability is also paramount. Over time, device degradation due to wear, corrosion, or material fatigue can impair performance and safety. This necessitates continuous monitoring, periodic maintenance, and, in some cases, eventual replacement of the device.

Key Market Trends

Advancements in Brain-Computer Interfaces (BCIs)

Technological advancements in brain-computer interfaces (BCIs) are reshaping the neuroprosthetics landscape. BCIs facilitate direct communication between the brain and external devices, offering transformative solutions for individuals with neurological impairments.

Non-invasive BCIs, typically based on electroencephalography (EEG), are gaining traction due to their ease of use and growing accessibility. These devices allow users to interact with computers or prosthetic limbs via thought alone, without requiring surgical intervention. Their potential applications extend beyond healthcare into areas such as assistive technology, gaming, and communication.

In parallel, invasive BCIs are advancing significantly. These systems involve implanting electrodes within the brain, enabling precise data capture and neural stimulation. Innovations in electrode design, implantation techniques, and data processing have greatly improved the accuracy, safety, and durability of these systems. Invasive BCIs are being explored for applications including limb restoration, neurological therapy, and cognitive enhancement.

Emerging hybrid BCIs-combining both invasive and non-invasive elements-seek to balance precision and usability. These systems aim to deliver high-performance control while minimizing surgical risks, offering a promising middle ground for future solutions.

Key Market Players

• Medtronic PLC
• LivaNova PLC
• Demant A/S
• MED-EL Corporation
• Cochlear Limited
• Abbott Laboratories
• Boston Scientific Corp
• Second Sight Medical Products, Inc.
• Retina Implant AG
• NeuroPace Inc

Report Scope:

In this report, the Neuroprosthetics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Neuroprosthetics Market, Type:

• Output Neural Prosthetics
• Input Neural Prosthetics

Neuroprosthetics Market, Technique:

• Spinal Cord Stimulation
• Deep Brain Stimulation
• Vagus Nerve Stimulation
• Other Techniques

Neuroprosthetics Market, Application:

• Parkinson's Disease
• Alzheimer's Disease
• Epilepsy
• Auditory Processing Disorders
• Ophthalmic Disorders
• Other Applications

Neuroprosthetics Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• Germany
• United Kingdom
• Italy
• France
• Spain
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Neuroprosthetics Market.

Available Customizations:

Neuroprosthetics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Neuroprosthetics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Output Neural Prosthetics, Input Neural Prosthetics)
  • 5.2.2. By Technique (Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Other Techniques)
  • 5.2.3. By Application (Parkinson's Disease, Alzheimer's Disease, Epilepsy, Auditory Processing Disorders, Ophthalmic Disorders, Other Applications)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Neuroprosthetics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Technique
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Neuroprosthetics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Technique
      • 6.3.1.2.3. By Application
  • 6.3.2. Mexico Neuroprosthetics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Technique
      • 6.3.2.2.3. By Application
  • 6.3.3. Canada Neuroprosthetics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Technique
      • 6.3.3.2.3. By Application

7. Europe Neuroprosthetics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Technique
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Neuroprosthetics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Technique
      • 7.3.1.2.3. By Application
  • 7.3.2. Germany Neuroprosthetics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Technique
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Neuroprosthetics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Technique
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Neuroprosthetics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Technique
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Neuroprosthetics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Technique
      • 7.3.5.2.3. By Application

8. Asia-Pacific Neuroprosthetics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Technique
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Neuroprosthetics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Technique
      • 8.3.1.2.3. By Application
  • 8.3.2. India Neuroprosthetics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Technique
      • 8.3.2.2.3. By Application
  • 8.3.3. South Korea Neuroprosthetics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Technique
      • 8.3.3.2.3. By Application
  • 8.3.4. Japan Neuroprosthetics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Technique
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Neuroprosthetics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Technique
      • 8.3.5.2.3. By Application

9. South America Neuroprosthetics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Technique
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Neuroprosthetics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Technique
      • 9.3.1.2.3. By Application
  • 9.3.2. Argentina Neuroprosthetics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Technique
      • 9.3.2.2.3. By Application
  • 9.3.3. Colombia Neuroprosthetics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Technique
      • 9.3.3.2.3. By Application

10. Middle East and Africa Neuroprosthetics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Technique
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Neuroprosthetics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Technique
      • 10.3.1.2.3. By Application
  • 10.3.2. Saudi Arabia Neuroprosthetics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Technique
      • 10.3.2.2.3. By Application
  • 10.3.3. UAE Neuroprosthetics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Technique
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Medtronic PLC
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. LivaNova PLC
• 14.3. Demant A/S
• 14.4. MED-EL Corporation
• 14.5. Cochlear Limited
• 14.6. Abbott Laboratories
• 14.7. Boston Scientific Corp
• 14.8. Second Sight Medical Products, Inc.
• 14.9. Retina Implant AG
• 14.10. NeuroPace Inc

15. Strategic Recommendations

16. About Us & Disclaimer